{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:36:39Z","timestamp":1789043799317,"version":"build-2803163510"},"reference-count":27,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s253078","type":"journal-article","created":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T20:41:31Z","timestamp":1602448891000},"page":"4221-4230","source":"Crossref","is-referenced-by-count":19,"title":["&lt;p&gt;Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions&lt;\/p&gt;"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Qingqing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanyin E","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1476-5381.1993.tb13877.x","volume":"110","author":"Criscione","year":"1993","journal-title":"Br J Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2165\/00003495-199754020-00009","volume":"54","author":"Markham","year":"1997","journal-title":"Drugs"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jamda.2017.09.023","volume":"19","author":"Spannella","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/HJH.0000000000001276","volume":"35","author":"Thomopoulos","year":"2017","journal-title":"J Hypertens"},{"key":"ref5","unstructured":"Federal food, drug, and cosmetic act, chapter v, subchapter a, drugs and devices section 355(j)(8)(B)(i)."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3797\/scipharm.1009-01","volume":"79","author":"Zaid","year":"2011","journal-title":"Sci Pharm"},{"key":"ref7","unstructured":"DIOVAN\u00ae(Valsartan) Capsules [Prescribing Information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2020."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1248\/cpb.38.3112","volume":"38","author":"Yamada","year":"1990","journal-title":"Chem Pharm Bull"},{"key":"ref9","first-page":"661","author":"Mansouri","year":"2017","journal-title":"J Pharm Pharmacol"},{"key":"ref10","first-page":"185","volume":"32","author":"Saydam","year":"2007","journal-title":"J Pharm Sci"},{"key":"ref11","unstructured":"National Medical Products Administration of China, Center for Drug Evaluation. Guideline for bioavailability and bioequivalence studies of generic drug products [in Chinese]. 2019."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/j.1552-4604.1997.tb04783.x","volume":"37","author":"Colussi","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s002280050259","volume":"52","author":"Flesch","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.clinthera.2014.01.004","volume":"36","author":"Kim","year":"2014","journal-title":"Clin Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.clinthera.2010.03.004","volume":"32","author":"Iqbal","year":"2010","journal-title":"Clin Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s002280050317","volume":"52","author":"Muller","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/(SICI)1099-081X(199805)19:4<237::AID-BDD100>3.0.CO;2-7","volume":"19","author":"Sioufi","year":"1998","journal-title":"Biopharm Drug Dispos"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5414\/CPP40035","volume":"40","author":"Sechaud","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.clinthera.2009.09.002","volume":"31","author":"Spinola","year":"2009","journal-title":"Clin Ther"},{"key":"ref20","unstructured":"World Medical Association Declaration of Helsinki (WMA). Ethical Principles for Medical Research Involving Human Subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the 52nd WMA General Assembly, Edinburgh, Scotland, October 7, 2000. Accessed, 2019."},{"key":"ref21","unstructured":"International Council for Harmonization of technical requirements for registration of pharmaceuticals for human use. Accessed, 2019."},{"key":"ref22","unstructured":"National Medical Products Administration of China. Guideline for good clinical practice [in Chinese]. Accessed, 2019."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jchromb.2008.10.018","volume":"876","author":"Hanpithakpong","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jchromb.2009.02.006","volume":"877","author":"Hodel","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref25","unstructured":"National Medical Products Administration of China. Technical guideline for clinical pharmacokinetics of chemical drugs [in Chinese]. Accessed, 2019."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1208\/s12248-012-9406-x","volume":"14","author":"Davit","year":"2012","journal-title":"AAPS J"},{"key":"ref27","first-page":"789","volume":"69","author":"Howe","year":"1974","journal-title":"J Amer Statist Assoc"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=62404","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=62404","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T20:41:37Z","timestamp":1602448897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/pharmacokinetics-and-bioequivalence-of-two-formulations-of-valsartan-8-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"URL":"https:\/\/doi.org\/10.2147\/dddt.s253078","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}